UK, China develop pancreatic cancer vaccine system

China |  News | 0 Comment | 28 Nov, 2019

Researchers from Queen Mary University of London and Zhengzhou University have developed a personalised vaccine system that could ultimately delay the onset of pancreatic cancer. ...Read more

Fosun Pharma inks $148M deal with US biotech startup

China |  News | 0 Comment | 27 Nov, 2019

US based biotech startup MimiVax LLC and Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. have announced that the companies have entered into a China-exclusive licensing a...Read more

Astellas to treat men with metastatic castration-resistant prostate cancer in China

China |  News | 0 Comment | 26 Nov, 2019

Astellas Pharma Inc.,  based in Tokyo, Japan has announced the China National Medical Products Administration (NMPA) approved a new drug application (NDA) for XTANDI® (en...Read more

Ascentage Pharma to open global centre in China

China |  News | 0 Comment | 26 Nov, 2019

US headquartered Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies, announced that the groundbreaking ceremony for the Company...Read more

WuXi Vaccines to invest $240 M for manufacturing facility in Ireland

China |  News | 0 Comment | 25 Nov, 2019

China based WuXi Biologics , a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development, and manufacturing, announ...Read more

InnoPack China to provide pharma packaging solutions to APAC Region

China |  News | 0 Comment | 22 Nov, 2019

InnoPack China, a flagship exhibition of pharmaceutical packaging and drug delivery system with a considerable scale in Asia and the world, organized by Informa Markets and C...Read more

WuXi STA forms strategic partnership with Impact Therapeutics

China |  News | 0 Comment | 22 Nov, 2019

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Impact Therapeutics, a China based biotech focused on innovative drug discovery and development in a...Read more

CStone announces first patient dosed in the Phase I study of ivosidenib

China |  News | 0 Comment | 20 Nov, 2019

CStone Pharmaceuticals on 20 Nov 2019 announced that the first patient has been dosed in Phase I bridging the registrational study of ivosidenib (TIBSOVO®) in China. This stand-alo...Read more

Baring Private Equity Asia to acquire Lumenis

China |  News | 0 Comment | 21 Nov, 2019

Baring Private Equity Asia (BPEA) has announced that its affiliated private equity funds have agreed to acquire Lumenis, a leading provider of specialty energy-based medical devices across ...Read more

WuXi Biologics Congratulates Tychan on the World’s First Yellow Fever Antibody

China |  News | 0 Comment | 19 Nov, 2019

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, congratula...Read more

WuXi AppTec’s LTD expands toxicology facility in China

China |  News | 0 Comment | 18 Nov, 2019

WuXi AppTec, a leading global provider of R&D and manufacturing services enabling companies in the pharmaceutical, biotechnology and medical device industries, has announced its Lab Tes...Read more

ITM, CIRC promote medical radioisotopes in China

China |  News | 0 Comment | 20 Nov, 2019

Germany based ITM Isotopen Technologien München AG (ITM), a biotechnology and radiopharmaceutical group of companies, and Chengdu Gaotong Isotope Co., Ltd. a subsidiary of China Isotop...Read more

NUS to set up research translation unit in China

China |  News | 0 Comment | 22 Nov, 2019

National University of Singapore (NUS) is collaborating with the People’s Government of Guangzhou Municipality and the Sino-Singapore Guangzhou Knowledge City Administration Committee...Read more

PSGL-1 immunotherapy to activate anti-tumor inflammatory response

China |  News | 0 Comment | 18 Nov, 2019

3SBio Inc. and Verseau Therapeutics, Inc. on 18 Nov 2019 announced the selection of VTX-0811, a monoclonal antibody targeting PSGL-1, as the first licensed program under thei...Read more

BeiGene receives its first FDA approval

China |  News | 0 Comment | 18 Nov, 2019

BeiGene, Ltd., China, a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of c...Read more

I-Mab to kick off clinical trials for monoclonal antibody TJM2 in China

China |  News | 0 Comment | 15 Nov, 2019

I-Mab Biopharma ("I-Mab"), a China and U.S.-based clinical-stage biopharmaceutical company exclusively focused on the discovery and development of novel or highly differentiated b...Read more

111 to establish healthcare retail channel with HEC

China |  News | 0 Comment | 15 Nov, 2019

111, Inc., a leading integrated online and offline healthcare platform, announced  that it will establish an integrated online and offline healthcare retail channel with HEC Group. The...Read more

Thermo Fisher opens customer solution center in China

China |  News | 0 Comment | 14 Nov, 2019

Thermo Fisher Scientific Inc., the world leader in serving science, has announced the official opening of a Customer Solution Center in Shanghai, China. This follows the recent announcement...Read more